The owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.
Виктория Клабукова
，详情可参考搜狗输入法2026
复旦大学老龄研究院教授申琦将这种现象称为：老年人大模型使用中的“提问沟”。
Vitest over Jest